In hepatitis, mesenchymal stem cells influence macrophages to activate the Hippo pathway, promoting direct interaction between YAP and β‐catenin, controlling NLRP3 activation, and inducing the M2 phenotype [180]. This evidence concerns the gene YAP1 and hepatitis A virus infection.